Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder

被引:27
|
作者
Kuzushima, K
Kimura, H
Hoshino, Y
Yoshimi, A
Tsuge, I
Horibe, K
Morishima, T
Tsurumi, T
Kojima, S
机构
[1] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] Nagoya Univ, Sch Med, Dept Pediat Dev Pediat, Nagoya, Aichi 466, Japan
[3] Nagoya Univ, Sch Med, Dept Hlth Sci, Nagoya, Aichi 466, Japan
来源
JOURNAL OF INFECTIOUS DISEASES | 2000年 / 182卷 / 03期
基金
日本学术振兴会;
关键词
D O I
10.1086/315791
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV)-associated lymphoproliferative disorder (LPD) is a serious complication after allogeneic bone marrow transplantation (BMT). Dynamics of EBV-specific cytotoxic T lymphocytes (CTL), which are important in controlling EBV during the LPD, have not been fully elucidated A patient with Wiskot-Aldrich's syndrome was diagnosed as suffering from LPD on day 47 after BMT. Fluorescence-activated cell sorter (FACS) analysis for interferon-gamma production revealed that >70% of the patient's CD8(+) T cells were EBV specific. The patient's lymphocytes were directly cytotoxic to donor-derived EBV-positive lymphoblastoid cells, which was blocked by an anti-class I antibody. EBV-specific CD8(+) T cell counts declined in parallel with EBV genome load, and full recovery of LPD was obtained with relaxation of immunosuppressive drags. The results illustrate longitudinal dynamics of EBV-specific CTL during the posttransplant LPD; they also illustrate the advantages of using FAGS analysis for EBV-specific CTL to make decisions about treatment.
引用
收藏
页码:937 / 940
页数:4
相关论文
共 50 条
  • [1] Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder
    Prockop, Susan E.
    Doubrovina, Ekaterina
    Baroudy, Karim
    Boulad, Farid
    Khalaf, Ramzi
    Papadopoulos, Esperanza B.
    Sauter, Craig
    Szenes, Victoria
    Suser, Stephanie
    Wasilewski, Gloria
    Ruggierio, Julianna
    O'Reilly, Richard J.
    CANCER RESEARCH, 2015, 75
  • [2] Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder
    Green, M.
    Michaels, M. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 41 - 54
  • [3] Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease
    Burns, DM
    Crawford, DH
    BLOOD REVIEWS, 2004, 18 (03) : 193 - 209
  • [4] Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
    Khanna, R
    Bell, S
    Sherritt, M
    Galbraith, A
    Burrows, SR
    Rafter, L
    Clarke, B
    Slaughter, R
    Falk, MC
    Douglass, J
    Williams, T
    Elliott, SL
    Moss, DJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10391 - 10396
  • [5] Epstein-Barr virus and posttransplant lymphoproliferative disease
    Holmes, R
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 33 (04): : 442 - 444
  • [6] Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
    Straathof, KCM
    Bollard, CM
    Popat, U
    Huls, MH
    Lopez, T
    Morriss, MC
    Gresik, MV
    Gee, AP
    Russell, HV
    Brenner, MK
    Rooney, CM
    Heslop, HE
    BLOOD, 2005, 105 (05) : 1898 - 1904
  • [7] Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes
    Lindsay, Julian
    Othman, Jad
    Heldman, Madeleine R.
    Slavin, Monica A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (06) : 635 - 645
  • [8] Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation
    Allen, U. D.
    Preiksaitis, J. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 107 - 120
  • [9] Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas
    Finberg, RW
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (05) : 349 - 353
  • [10] Adoptive Transfer of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocytes for the Treatment of Angiocentric Lymphomas
    Eun-Kyung Kim
    Sung-Hee Yoon
    Hyun-Il Cho
    Tai-Gyu Kim
    Young Seon Hong
    Myung Ah Lee
    Chun-Choo Kim
    International Journal of Hematology, 2006, 83 : 66 - 73